Clinical Trial Update: Post-Approval Study of MelaFind

View source ↗

Summary

Post-approval study of the melanoma diagnostic device MelaFind has been terminated (status: TERMINATED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MelaFind

Snippet

Sponsor: MELA Sciences, Inc. | Conditions: Melanoma | Status: TERMINATED